tiprankstipranks
Intellia Therapeutics (NTLA)
NASDAQ:NTLA
US Market
NTLA
Intellia Therapeutics
RESEARCH TOOLSreports

Intellia Therapeutics (NTLA) Cash flow

Compare
4,703 Followers

Intellia Therapeutics Cash Flow

NTLA's free cash flow for Q4 2025 was $-69.41M. For the 2025 fiscal year, NTLA's free cash flow was decreased by $0.00 and operating cash flow was $-69.28M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ -348.88M$ -348.88M$ -394.09M$ -333.29M$ -225.03M
Investing Cash Flow
$ 125.57M$ 125.57M$ -31.35M$ 160.31M$ -550.78M
Financing Cash Flow
$ 185.75M$ 185.75M$ 130.32M$ 582.96M$ 736.69M
End Cash Position
$ 202.79M$ 202.79M$ 240.35M$ 535.46M$ 125.49M
Free Cash Flow
$ -354.66M$ -354.66M$ -408.07M$ -391.68M$ -237.79M
Currency in USD

Intellia Therapeutics Cash Flow